# Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer

> **NCT00347438** · PHASE2 · TERMINATED · sponsor: **University of Chicago** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00347438
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** a result of slow accrual
- **Last updated:** 2015-12-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00347438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00347438, "Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00347438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*